Zyn sold 794 million cans in the U.S. last financial year — up 37%. In Silicon Valley, founders and engineers are treating 6-milligram nicotine pouches as smoke-free stimulants for long workdays, with some companies even handing them out at work.

Big numbers, quiet spread The growth in nicotine-pouch sales is concrete. Zyn, owned by Philip Morris International, distributed 794 million cans in the U.S. in the last financial year, a rise of 37 percent from the previous year. That's rapid adoption on a national scale. What looks like a retail story is playing out in offices. Tech companies and startups are offering pouches in kitchens and at desks. At least one large AI firm now provides them free to staff, signaling nicotine's steady move into professional settings where smoke and vapor were once taboo. A new productivity ritual Nicotine pouches remove smoke, smell and much of the social stigma that kept many people from using nicotine at work. The products contain tobacco-free nicotine salts combined with artificial sweeteners and synthetic fibers and sit under the lip like small, silent stimulants. Each 6-milligram pouch is marketed and used as a potent dose. Users and some promotional materials compare that amount to the nicotine in multiple cigarettes, which helps explain why a single pouch can sustain a long stretch of focused activity. For many in fast-moving tech jobs, that sustained effect is the selling point. Why founders and engineers are drawn to pouches - Personal account: Garrett Campbell, a 26-year-old software founder, says he keeps a 6-mg “cool mint” pouch in place for much of the day and swaps it every few hours. - Productivity: Campbell and other users describe the effect as both stimulating and calming — a steady focus that helps during marathon calls and coding sessions. - Social dynamic: Among men in tech, the pouches have become a shared ritual — a discreet way to chase alertness without the interruptions or odor of smoking. That camaraderie mirrors earlier patterns in other fields. Workplace implications Allowing free access or normalizing pouch use in common areas alters break norms and blurs the line between personal habit and company provision. For some firms, offering pouches looks like a convenience or perk; for others, it raises questions about liability and workplace health policy. The shift also affects how nicotine is marketed: without smoke, products can be framed as performance tools or lifestyle enhancers, expanding acceptance beyond longtime smokers. This shift matters beyond office habit: it recasts nicotine as a productivity tool, pushing employers to decide whether pouches are perks, workplace hazards or somewhere in between. Those choices will shape HR policy, benefits packages and the marketing playbook for tobacco companies. Health and perception Pouches are pitched as a cleaner alternative to cigarettes and vaping because removing combustion eliminates smoke-related odors and many byproducts of burning tobacco. But the products still deliver nicotine, a stimulant that affects heart rate, blood pressure and reward pathways in the brain.

Related Articles

The number to watch is simple: Zyn moved 794 million cans in the last financial year — an unmistakable sign nicotine is sliding into U.S. workplaces.

This article was created with AI assistance.